Michael J. Bollong

2.1k total citations
42 papers, 1.4k citations indexed

About

Michael J. Bollong is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Michael J. Bollong has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 12 papers in Cell Biology and 5 papers in Organic Chemistry. Recurrent topics in Michael J. Bollong's work include Genomics, phytochemicals, and oxidative stress (9 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and Cellular Mechanics and Interactions (4 papers). Michael J. Bollong is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (9 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and Cellular Mechanics and Interactions (4 papers). Michael J. Bollong collaborates with scholars based in United States, South Korea and Canada. Michael J. Bollong's co-authors include Peter G. Schultz, Luke L. Lairson, Arnab K. Chatterjee, Claudio Zambaldo, Insha Ahmad, Emily N. Chin, Costas A. Lyssiotis, R. Luke Wiseman, Hwayoung Yun and Raymond E. Moellering and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael J. Bollong

39 papers receiving 1.3k citations

Peers

Countries citing papers authored by Michael J. Bollong

Since Specialization

Citations

This map shows the geographic impact of Michael J. Bollong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Bollong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Bollong more than expected).

Fields of papers citing papers by Michael J. Bollong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Bollong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Bollong. The network helps show where Michael J. Bollong may publish in the future.

Co-authorship network of co-authors of Michael J. Bollong

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Bollong. A scholar is included among the top collaborators of Michael J. Bollong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Bollong. Michael J. Bollong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Augmented Acyl-CoA Biosynthesis Promotes Resistance to TEAD Palmitoylation Site Inhibition 2025 ·ACS Chemical Biology ·(unknown), (unknown), (unknown), Michael A. Erb, (unknown), James J. Galligan, Michael J. Bollong	2
2	TERT activation targets DNA methylation and multiple aging hallmarks 2024 ·Cell ·Hong Seok Shim, (unknown), Xiaoying Shang, Jiexi Li, (unknown), (unknown), (unknown), (unknown), Luke L. Lairson, Adam T. Boutin, Michael J. Bollong, Peter G. Schultz, Ronald A. DePinho	42
3	Pharmacological expansion of type 2 alveolar epithelial cells promotes regenerative lower airway repair 2024 ·Proceedings of the National Academy of Sciences ·Sida Shao, Nan Zhang, (unknown), (unknown), (unknown), Qiangwei Fu, David Huang, (unknown), Jian Shu, Alain Domissy, Shuangwei Li, Vân Nguyên-Trân, Sean B. Joseph, Arnab K. Chatterjee, (unknown), Peter G. Schultz, Michael J. Bollong	10
4	HPPE Activates NRF2 Signaling by Liberating Heavy Metal Stores 2024 ·ChemBioChem ·(unknown), Michael J. Bollong	1
5	Optimization of 3-aminotetrahydrothiophene 1,1-dioxides with improved potency and efficacy as non-electrophilic antioxidant response element (ARE) activators 2023 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Jisu Kim, (unknown), (unknown), (unknown), (unknown), Hyung Ryong Moon, Yunjin Jung, R. Luke Wiseman, Luke L. Lairson, Arnab K. Chatterjee, Michael J. Bollong, Hwayoung Yun	2
6	A high throughput screen for pharmacological inhibitors of the carbohydrate response element 2023 ·Scientific Data ·(unknown), Michael J. Bollong	3
7	A covalent inhibitor of the YAP–TEAD transcriptional complex identified by high-throughput screening 2023 ·RSC Chemical Biology ·(unknown), (unknown), Emily Chen, Mitchell Hull, Arnab K. Chatterjee, (unknown), Michael J. Bollong	3
8	Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and Activation 2023 ·Israel Journal of Chemistry ·Jessica D. Rosarda, (unknown), Emily Chen, Michael J. Bollong, R. Luke Wiseman	2
9	Succinylation of a KEAP1 sensor lysine promotes NRF2 activation 2023 ·Cell chemical biology ·(unknown), (unknown), (unknown), (unknown), (unknown), Yeonjin Ko, Gabriel C. Lander, R. Luke Wiseman, Michael J. Bollong	18
10	Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras -driven lung cancer 2022 ·Science Advances ·Marie Pariollaud, (unknown), (unknown), (unknown), Alanna B. Chan, Brian J. Altman, Reuben J. Shaw, Michael J. Bollong, R. Luke Wiseman, Katja Lamia	27
11	Synthesis and biological evaluation of novel FiVe1 derivatives as potent and selective agents for the treatment of mesenchymal cancers 2022 ·European Journal of Medicinal Chemistry ·Francisco Martínez‐Peña, (unknown), (unknown), Nick A. Kuburich, Sendurai A. Mani, Peter G. Schultz, Michael J. Bollong, Luke L. Lairson	3
12	CRY2 missense mutations suppress P53 and enhance cell growth 2021 ·Proceedings of the National Academy of Sciences ·Alanna B. Chan, (unknown), Jennifer L. Fribourgh, (unknown), Michael J. Bollong, Carrie L. Partch, Katja Lamia	25
13	A short ORF-encoded transcriptional regulator 2021 ·Proceedings of the National Academy of Sciences ·Minseob Koh, Insha Ahmad, Yeonjin Ko, Yuxiang Zhang, Thomas F. Martínez, Jolene K. Diedrich, Qian Chu, James J. Moresco, Michael A. Erb, Alan Saghatelian, Peter G. Schultz, Michael J. Bollong	38
14	YAP-dependent proliferation by a small molecule targeting annexin A2 2021 ·Nature Chemical Biology ·Sophia Z. Shalhout, Pengyu Yang, Edyta M. Grzelak, (unknown), Sida Shao, Claudio Zambaldo, (unknown), (unknown), (unknown), (unknown), Emily Chen, Michael DeRan, Sijia Li, Mitchell Hull, Xu Wu, Arnab K. Chatterjee, Weijun Shen, Fernando D. Camargo, Peter G. Schultz, Michael J. Bollong	44
15	Discovery and SAR studies of 3-amino-4-(phenylsulfonyl)tetrahydrothiophene 1,1-dioxides as non-electrophilic antioxidant response element (ARE) activators 2021 ·Bioorganic Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Yunjin Jung, Luke L. Lairson, Arnab K. Chatterjee, Peter G. Schultz, Michael J. Bollong, Hwayoung Yun	8
16	2-Sulfonylpyridines as Tunable, Cysteine-Reactive Electrophiles 2020 ·Journal of the American Chemical Society ·Claudio Zambaldo, Ekaterina V. Vinogradova, Xiaotian Qi, (unknown), Radu M. Suciu, Minseob Koh, (unknown), (unknown), Brittany B. Sanchez, Jason S. Chen, Arnab K. Chatterjee, Peng Liu, Peter G. Schultz, Benjamin F. Cravatt, Michael J. Bollong	70
17	A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer 2019 ·Proceedings of the National Academy of Sciences ·Natasha C. Lucki, Genaro R. Villa, (unknown), Michael J. Bollong, (unknown), Jae Wook Lee, Justin L. Anglin, (unknown), Emily N. Chin, (unknown), Kevin C. Johnson, Philipp N. Sander, Perry Gordon, Stephen Skirboll, Heiko Wurdak, Peter G. Schultz, Paul S. Mischel, Luke L. Lairson	25
18	Small molecule-mediated inhibition of myofibroblast transdifferentiation for the treatment of fibrosis 2017 ·Proceedings of the National Academy of Sciences ·Michael J. Bollong, Baiyuan Yang, (unknown), (unknown), Emily N. Chin, Claudio Zambaldo, Danling Wang, Arnab K. Chatterjee, Luke L. Lairson, Peter G. Schultz	55
19	P-262 A PDE4 Inhibitor-antibody Conjugate for Treating Ulcerative Colitis 2017 ·Inflammatory Bowel Diseases ·Shan Yu, (unknown), Reyna K. V. Lim, David T. Rodgers, Sijia Li, (unknown), (unknown), Eric Hampton, Michael J. Bollong, Jiayin Shen, (unknown), Danling Wang, Ashley Woods, Timothy M. Wright, Peter G. Schultz, Stephanie A. Kazane, Travis S. Young, Matthew S. Tremblay	1
20	Pan‐Src Family Kinase Inhibitors Replace Sox2 during the Direct Reprogramming of Somatic Cells 2011 ·Angewandte Chemie International Edition ·Judith Staerk, Costas A. Lyssiotis, (unknown), Michael J. Bollong, Ruth K. Foreman, Shoutian Zhu, Michael Garcia, Qing Gao, Laure C. Bouchez, Luke L. Lairson, Bradley D. Charette, Ľubica Supeková, (unknown), Achim Brinker, Charles Y. Cho, Rudolf Jaenisch, Peter G. Schultz	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact